Popular topics to explore
MANIPALHOS
Manipal Health Enterprises Ltd (MANIPALHEALTH) Q1 FY27 Results:
Company reports consolidated net profit of ₹2.32 billion vs ₹2.5 billion YoY, with revenue rising to ₹30.91 billion vs ₹22.38 billion YoY. EBITDA stood at ₹7.36 billion vs ₹5.86 billion YoY, while EBITDA margin declined to 23.80% vs 26.20% YoY.
📊 Q1 FY27 Highlights
Net Profit: ₹2.32B vs ₹2.5B (YoY)
Revenue: ₹30.91B vs ₹22.38B (YoY)
EBITDA: ₹7.36B vs ₹5.86B (YoY)
EBITDA Margin: 23.80% vs 26.20% (YoY)
📌 SWOT Analysis
Strengths
Strong revenue growth (+38% YoY).
Expanding hospital network across India.
Diversified healthcare services portfolio.
Weaknesses
Margin compression (EBITDA margin down ~240 bps YoY).
High operating costs in new facilities.
Opportunities
Rising demand for private healthcare in India.
Potential for medical tourism growth.
Digital health and telemedicine expansion.
Threats
Regulatory scrutiny on healthcare pricing.
Competition from Apollo, Fortis, and Max Healthcare.
Talent retention in specialized medical fields.
🏭 Fundamentals Snapshot (FY26)
Revenue: ~₹110 billion
EBITDA Margin: ~24%
PAT: ~₹9.5 billion
Debt-to-Equity: ~0.4
Capex Plan: Expansion of hospital network across Tier‑1 & Tier‑2 cities#MacroViews#PsychologyofMoney#Miscellaneous#PersonalFinance#EquityResearch
446 likes·54 comments

















